Andrew Berman, MD
Plastic Surgery within the Head & Neck · Beverly Hills, CANPI 1427172709
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 147 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 25 manufacturers reported payments, led by Regeneron Healthcare Solutions, Inc. at 27.1% of the total.
Across 147 payments — averaging $24.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$989
- Novartis$438
- Sanofi$309
- Amgen$222
- Optinose US, Inc.$213
- Hikma Pharmaceuticals USA$199
- plus $1K from 19 others
What the payments were for
- Food & beverage$3,645100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 35 | $989 |
| Novartis | 16 | $438 |
| Sanofi | 12 | $309 |
| Amgen | 9 | $222 |
| Optinose US, Inc. | 10 | $213 |
| Hikma Pharmaceuticals USA | 10 | $199 |
| Incyte Corporation | 8 | $197 |
| Octapharma USA, Inc. | 7 | $179 |
| Merz North America, Inc. | 7 | $142 |
| GSK | 4 | $100 |
| Stryker | 3 | $82 |
| Boehringer Ingelheim | 4 | $81 |
| Eyevance Pharmaceuticals LLC | 4 | $75 |
| Genentech USA, Inc. | 3 | $75 |
| AstraZeneca | 3 | $64 |
| CSL Behring | 2 | $46 |
| Lilly USA, LLC | 1 | $35 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $34 |
| Phadia US Inc. | 2 | $33 |
| Biocryst Pharmaceuticals, Inc. | 1 | $30 |
| Teva Pharmaceuticals USA, Inc. | 1 | $26 |
| Circassia Inc. | 1 | $23 |
| Shire North American Group Inc | 1 | $22 |
| Masimo Corporation | 1 | $17 |
| Galderma Laboratories, L.p. | 1 | $14 |
How this compares
$3,645 in reported general payments places this provider in the 75th percentile of 119 plastic surgery within the head & neck providers in California.
See all plastic surgery within the head & neck providers in California →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other plastic surgery within the head & neck in Beverly Hills
- William BinderBeverly Hills$136.4M
- Rajesh ChopraBeverly Hills$75K
- Donald YooBeverly Hills$12K
- Christopher ZoumalanBeverly Hills$11K
- Fadi ChahinBeverly Hills$2K
- Babak LarianBeverly Hills$2K
- Francis PalmerBeverly Hills$797
- Jivianne LeeSanta Monica$324K
- John JosephEncino$252K
- Ronald KochMountain View$37K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.